But at the time the company was considering the trial, Peter Johannsen, international medical vice president of Novo Nordisk, told Being Patient that blood biomarkers werent developed to the extent where they could be used to screen for people at-risk while cognitively healthy and would require PET scans or lumbar punctures, making a large study difficult to run
Protocol 3: the twice-weekly split dose approach Goal: Flatten the concentration curve to eliminate end-of-week symptom return Schedule (any compounded GLP-1): Take half your weekly dose every 3.5 days (e.g., Monday morning and Thursday evening) Total weekly dose remains identical Escalate total weekly dose at the same rate as your original plan Why the plotter supports this: The plotter shows a dramatic difference between once-weekly and twice-weekly dosing curves at the same total weekly dose
By entering this site, you are accepting our Terms and Conditions
In other words GLP-1s and there are a range of these treatments all have an effect which is predominantly around high sugars and if the sugar becomes low, the effect is switched off, and it is the reason we see very low rates of low blood sugars so called 'hypos', or hypoglycemic episodes that occur with GLP1 treatments